Ignite Creation Date:
2025-12-25 @ 4:05 AM
Ignite Modification Date:
2026-01-11 @ 2:08 PM
Study NCT ID:
NCT03020602
Status:
COMPLETED
Last Update Posted:
2021-08-10
First Post:
2017-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BPM31510 in Treating Patients With Recurrent High-Grade Glioma Previously Treated With Bevacizumab
Sponsor:
Seema Nagpal
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-04
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-26
Completion Date Type:
ACTUAL
First Submit Date:
2017-01-05
First Submit QC Date:
None
Study First Post Date:
2017-01-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-09
Last Update Post Date:
2021-08-10
Last Update Post Date Type:
ACTUAL